0001744769-18-000001.txt : 20180629 0001744769-18-000001.hdr.sgml : 20180629 20180628185922 ACCESSION NUMBER: 0001744769-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180629 DATE AS OF CHANGE: 20180628 EFFECTIVENESS DATE: 20180629 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Attune Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001744769 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-315744 FILM NUMBER: 18926729 BUSINESS ADDRESS: STREET 1: 250 WEST 55TH STREET, 34TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 1(646) 597-6987 MAIL ADDRESS: STREET 1: 250 WEST 55TH STREET, 34TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 D 1 primary_doc.xml X0708 D LIVE 0001744769 Attune Pharmaceuticals, Inc. 250 WEST 55TH STREET, 34TH FLOOR NEW YORK NY NEW YORK 10019 1-646-597-6987 DELAWARE Attune Pharmaceuticals, LLC None Corporation true 2018 Andrew McDonald 250 WEST 55TH STREET, 34TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer Director Adam Tomasi 250 WEST 55TH STREET, 34TH FLOOR NEW YORK NY NEW YORK 10019 Director Roderick Wong 250 WEST 55TH STREET, 34TH FLOOR NEW YORK NY NEW YORK 10019 Director Jason Bablak 250 WEST 55TH STREET, 34TH FLOOR NEW YORK NY NEW YORK 10019 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2018-06-15 false true false 0 23584679 23319984 264695 Total Amount Sold includes both cash and amounts paid pursuant to conversion of indebtedness. false 11 0 0 0 false Attune Pharmaceuticals, Inc. Andrew McDonald Andrew McDonald President and CEO 2018-06-28